Pages that link to "Q36934339"
Jump to navigation
Jump to search
The following pages link to Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis (Q36934339):
Displaying 50 items.
- Integrated therapy for HIV and tuberculosis (Q26749428) (← links)
- HIV treatment cascade in tuberculosis patients (Q26782208) (← links)
- HIV and tuberculosis--science and implementation to turn the tide and reduce deaths (Q26824501) (← links)
- Diagnosis & treatment of tuberculosis in HIV co-infected patients (Q26991633) (← links)
- The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis (Q27014121) (← links)
- The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomi (Q27303476) (← links)
- Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis (Q28069032) (← links)
- Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge (Q28088557) (← links)
- Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review (Q28484857) (← links)
- Modelling HIV and MTB co-infection including combined treatment strategies (Q28485357) (← links)
- Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis (Q28486096) (← links)
- Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam (Q28538952) (← links)
- Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Q28547436) (← links)
- Pipeline of drugs for related diseases: tuberculosis (Q28818217) (← links)
- The 15th Bangkok International Symposium on HIV Medicine (Q29396779) (← links)
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis (Q30235074) (← links)
- Community-Acquired Pneumonia in HIV-Positive Patients: an Update on Etiologies, Epidemiology and Management. (Q30238577) (← links)
- Recent advances in tuberculosis: New drugs and treatment regimens. (Q30360811) (← links)
- Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. (Q30378028) (← links)
- Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar (Q30383131) (← links)
- Understanding pharmacokinetics to improve tuberculosis treatment outcome (Q30411703) (← links)
- The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review (Q30658709) (← links)
- Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda (Q31106576) (← links)
- Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study (Q31141015) (← links)
- Tuberculosis and HIV co-infection in children. (Q33592322) (← links)
- The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study (Q33758612) (← links)
- French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults (Q33775397) (← links)
- Tuberculosis in tropical areas and immigrants (Q33778365) (← links)
- Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa. (Q33892396) (← links)
- Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana (Q33922724) (← links)
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis (Q33926262) (← links)
- New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline (Q34005593) (← links)
- Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis (Q34024416) (← links)
- Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin (Q34057466) (← links)
- Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report (Q34076558) (← links)
- Tuberculosis in children. (Q34083196) (← links)
- Update on opportunistic infections in the era of effective antiretroviral therapy (Q34085853) (← links)
- Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults (Q34098274) (← links)
- Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial (Q34137755) (← links)
- Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011) (Q34169277) (← links)
- Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164. (Q34202331) (← links)
- CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection (Q34204890) (← links)
- Current approaches to tuberculosis in the United States (Q34279727) (← links)
- Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients. (Q34311748) (← links)
- Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations (Q34321843) (← links)
- Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis (Q34387168) (← links)
- Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART. (Q34438327) (← links)
- The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study (Q34447727) (← links)
- Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review (Q34455442) (← links)
- Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa (Q34477198) (← links)